Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter trial of antibiotic combinations to eradicate early Pseudomonas aeruginosa infection in cystic fibrosis patients
2011-006171-19Phase 4Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Jan 2012
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cystic fibrosis (CF) and Pseudomonas aeruginosa airway infection comparing ciprofloxacin + inhaled colistin with ciprofloxacin + inhaled tobramycin (2 arms). Primary endpoint: Eradication of early infection. Started Jan 2012; status: active.
02
Drugs
ciprofloxacincolistintobramycin
03
Conditions
cystic fibrosis (CF)Pseudomonas aeruginosa airway infection
Beyond the preview
Go deeper on 2011-006171-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-006171-19.